Evaluating Dostarlimab for Endometrial Cancer Safety

Created using ChatSlide

This study protocol outlines a Phase 4 clinical trial focusing on endometrial cancer treatment with dostarlimab, detailing the study's design, safety objectives, and enrollment criteria. It specifies participant eligibility, including inclusion and exclusion criteria, and addresses considerations for pregnancy and prior therapies. The treatment regimen combines dostarlimab with carboplatin and paclitaxel, with ongoing safety monitoring and maintenance dosing through Cycle 30, ensuring...